+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Not all head-to-head trials are created equal: results from an open-label, short-term study seem inconsistent with previous donepezil literature



Not all head-to-head trials are created equal: results from an open-label, short-term study seem inconsistent with previous donepezil literature



International Journal of Geriatric Psychiatry 20(1): 85-7; Author Reply 87-9




(PDF emailed within 0-6 h: $19.90)

Accession: 049711408

Download citation: RISBibTeXText

PMID: 15635772

DOI: 10.1002/gps.1233


Related references

A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children. Health Technology Assessment 15(45): V-Vi, Xi-Xiii, 1-128, 2012

Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study. Dementia and Geriatric Cognitive Disorders 36(3-4): 229-241, 2014

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: An interim analysis of the results of a US multicentre open label extension study. European Neuropsychopharmacology 8(1): 67-75, 1998

Pregabalin vs. opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label study. Pain Practice 14(1): 32-42, 2014

Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan. Dementia and Geriatric Cognitive Disorders 27(3): 232-239, 2009

A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. American Journal of Transplantation, 2016

Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials. Clinical Therapeutics 28(6): 943-952, 2006

Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial. Alzheimer's Research & Therapy 7(1): 5-5, 2015

Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study. Paediatric Drugs 18(4): 319-329, 2016

REGARD: what can we learn from randomised, open-label, head-to-head studies?. Lancet. Neurology 7(10): 864-866, 2008

Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials. Epilepsia 56(6): 906-914, 2015

Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study. Primary Care Companion to the Journal of Clinical Psychiatry 7(2): 43-48, 2005

Radial head arthroplasty with an uncemented modular metallic radial head prosthesis: short- and mid-term results. European Journal of Trauma and Emergency Surgery 37(1): 85-95, 2011